Clinical trial data "one-stop shopping" public registry proposed by Sens. Feinstein and Snowe.
CLINICAL TRIAL DATA "ONE-STOP SHOPPING" PUBLIC REGISTRY for people with serious or life-threatening diseases will boost participation in clinical research, Sen. Feinstein (D-Calif.) said Aug. 2 in introducing a bill (S 2024) to create such a registry. "With a national database enabling people to find research trials, more people could be available to participate in research. This can help researchers broaden their pool of research participants," Feinstein said. Sen. Snowe (R-Maine) is co-sponsoring the legislation.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth